Naphak Modhiran
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
IgG3 Hinge Architecture Expands Dengue Virus Breadth of A Quaternary Epitope Dependent Zika Virus Cross-Neutralizing Antibody.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Heritable transgenic schistosomes as a living platform for SARS-CoV-2 neutralizing antibody secretion.
Journal: Nature communications
Published: February 26, 2026
Cloning, expression and characterisation of antigen-specific recombinant bat immunoglobulin from the black flying fox (Pteropus alecto).
Journal: Frontiers in immunology
Published: November 10, 2025
Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.
Journal: Nature communications
Published: November 05, 2025
Unique molecular profiling of monocyte responses to a high dose of DENV-NS1 reflected the effect of NS1 on hemostasis.
Journal: Medical microbiology and immunology
Published: October 05, 2025
Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial.
Journal: The Journal of infectious diseases
Published: July 03, 2025
Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024.
Journal: Journal of virology
Published: April 25, 2025
Henipavirus in Northern Short-Tailed Shrew, Alabama, USA.
Journal: Emerging infectious diseases
Published: February 21, 2025
Transcriptome Analysis of Monocytes Treated With Dengue Virus Nonstructural Protein 1 Revealed a Shift in Transcripts Involved in Self-Propagated Proinflammation and Antiviral Responses.
Journal: The Journal of infectious diseases
Published: December 19, 2024
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus.
Journal: PLoS pathogens
Published: December 13, 2024
Vaccine-Induced and Hybrid Immunity Against SARS-CoV-2 Variants of Concern in Two Cohorts in Queensland, Australia (2021-2022).
Journal: Journal of medical virology
Published: November 11, 2024
Last Updated: 09/26/2026